Dynamic contrast-enhanced MRI and sonography in patients receiving primary chemotherapy for breast cancer

Filippo Montemurro, Laura Martincich, Giovanni De Rosa, Stefano Cirillo, Vincenzo Marra, Nicoletta Biglia, Marco Gatti, Piero Sismondi, Massimo Aglietta, Daniele Regge

Research output: Contribution to journalArticlepeer-review

Abstract

We compared dynamic contrast-enhanced MRI (DCE-MRI) and sonography (US) for monitoring tumour size in 21 patients with breast cancer undergoing primary chemotherapy (PCT) followed by surgery. The correlation between DCE-MRI and US measurements of tumour size, defined as the product of the two major diameters, was 0.555 (P =0.009), 0.782 (P2, P2, P=0.009). After PCT, the median tumour size measured by the two techniques was similar (256 vs 289 mm2 for DCE-MRI and US, respectively, P=0.859). The correlation with the histopathological major tumour diameter was 0.824 (P

Original languageEnglish
Pages (from-to)1224-1233
Number of pages10
JournalEuropean Radiology
Volume15
Issue number6
DOIs
Publication statusPublished - Jun 2005

Keywords

  • Breast neoplasms
  • Magnetic resonance imaging
  • Primary chemotherapy
  • Sonography

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Fingerprint

Dive into the research topics of 'Dynamic contrast-enhanced MRI and sonography in patients receiving primary chemotherapy for breast cancer'. Together they form a unique fingerprint.

Cite this